William Michael Kavanaugh Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for William Michael Kavanaugh.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of William Michael Kavanaugh. William Michael Kavanaugh is SVP & Chief Scientific Officer in FIVE PRIME THERAPEUTICS INC ($FPRX) and Chief Scientific Officer and in CytomX Therapeutics, Inc. ($CTMX) and CSO, Head Res.&Non-Clin. Dev. in CytomX Therapeutics, Inc. ($CTMX).

Latest Insider Trading Transactions of William Michael Kavanaugh

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CTMX, FPRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 19 2020CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA7.13120,000855,600120,000
Jan 29 2019CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA16.8590,0001,516,50090,000
Jan 26 2018CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA25.8275,0001,936,50075,000
Dec 12 2017CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseM1.575,1308,079240,912
Dec 12 2017CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...BuyM1.575,1308,07919,04713.9 K to 19 K (+36.86 %)
Oct 06 2017CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseM4.4748,368216,34048,368
Oct 06 2017CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...SellS24.3448,3681,177,27713,91762.3 K to 13.9 K (-77.66 %)
Oct 06 2017CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...BuyM4.4748,368216,34062,28513.9 K to 62.3 K (+347.55 %)
Apr 17 2017CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA4.4748,368216,34096,736
Jan 27 2017CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA11.94120,0001,432,800120,000
Sep 28 2016CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA4.4748,368216,34048,368
Jan 25 2016CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA14.4680,0001,156,80080,000
Dec 31 2015CTMXCytomX Therapeutic ...Kavanaugh William MichaelChief Scientific Of ...Option ExerciseM6.618,91758,98376,688
Dec 31 2015CTMXCytomX Therapeutic ...Kavanaugh William MichaelChief Scientific Of ...BuyM6.618,91758,98313,9175 K to 13.9 K (+178.34 %)
Oct 16 2015CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA6.6185,605566,25185,605
Oct 16 2015CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...Option ExerciseA1.57246,042387,492246,042
Oct 16 2015CTMXCytomX Therapeutic ...Kavanaugh William MichaelCSO, Head Res.&Non- ...BuyP12.005,00060,0005,0000 to 5 K
Aug 26 2014FPRXFIVE PRIME THERAPE ...Kavanaugh William MichaelSVP & Chief Scienti ...Option ExerciseA11.1415,000167,10015,000

Page:   1